Keyphrases
High Risk
100%
Cardiovascular Risk
100%
Type 2 Diabetes Mellitus Patients
100%
Cardiovascular Events
100%
Oral Antidiabetic Drugs
100%
Multifactorial Approach
75%
Indonesia
50%
Type 2 Diabetes Mellitus (T2DM)
50%
Diabetes Mellitus Type 2
50%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
50%
Trial Outcomes
50%
Cardiovascular Outcome Trials
50%
Control Control
25%
Blood Pressure
25%
Risk Reduction
25%
Blood Glucose
25%
Aspirin
25%
Dipeptidyl peptidase-4 (DPP-4)
25%
Sulfonylurea
25%
Metformin
25%
Low Risk
25%
Lipids
25%
α-glucosidase Inhibitor
25%
Management Guidelines
25%
Quality Control
25%
Quality Cost
25%
Cost Control
25%
Diabetes Drugs
25%
American Diabetes Association
25%
Pharmacology, Toxicology and Pharmaceutical Science
Oral Antidiabetic Agent
100%
Non Insulin Dependent Diabetes Mellitus
100%
Acetylsalicylic Acid
50%
Dipeptidyl Peptidase IV Inhibitor
50%
Sulfonylurea
50%
Metformin
50%
Alpha-Glucosidase Inhibitor
50%
Medicine and Dentistry
Cardiovascular System
100%
Maturity Onset Diabetes of the Young
100%
Oral Antidiabetic Agent
100%
Health Care Cost
33%
Diabetes
22%
Blood Glucose
11%
Acetylsalicylic Acid
11%
Sulfonylurea
11%
Glycon
11%
Type 2 Diabetes
11%
Blood Pressure
11%
Dipeptidyl Peptidase-4 Inhibitor
11%
Alpha-Glucosidase Inhibitor
11%